Atea Pharmaceuticals, Inc. Liquidation Value
AVIR
Other
Cash & Equivalents
$95.71M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $95.71M
Total Obligations: -$40.63M
$55.09M
Per share: $0.71
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $95.71M
AR: $0
Total Obligations: -$40.63M
$55.09M
Per share: $0.71
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $95.71M
AR: $0
Inventory: $0
Total Obligations: -$40.63M
$55.09M
Per share: $0.71
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $55.09M | $0.71 |
| Liquid Liquidation Value | $55.09M | $0.71 |
| Operating Liquidation Value | $55.09M | $0.71 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $95.71M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $39.78M |
| Long-term Debt | N/A |
| Op. Lease Liability | $843,000 |
| Finance Lease | N/A |
| Shares Outstanding | 78.1M |
Explore all 158 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $95.71M | N/A | N/A | $12.95M | $39.78M | N/A | $843,000 | N/A |
| 2025-09-30 | $77.34M | N/A | N/A | $3.52M | $20.18M | N/A | $1.04M | N/A |
| 2025-06-30 | $87.72M | N/A | N/A | $8.84M | $20.12M | N/A | $1.25M | N/A |
| 2025-03-31 | $119.39M | N/A | N/A | $7.39M | $21.75M | N/A | $1.45M | N/A |
▼ Community Notes